Unraveling Structural Fragility in Global Healthcare Supply Chains
DOI:
https://doi.org/10.5281/zenodo.20443695Keywords:
Healthcare supply chain resilience,Medical supply shortages,Global health crisis preparedness,Pandemic-induced supply disruptions,Critical medical logistics,Pharmaceutical supply chain risk,Medical device availability,Just-in-time inventory failures,Global sourcing dependencies,Health system operational resilience,Emergency procurement strategies,Supply chain risk management in healthcare,Vaccine and PPE distribution challenges,Health infrastructure fragility,Crisis-driven supply chain adaptation.Abstract
Healthcare supply chains have long been viewed as an overly complex, costly ecosystem. Visibility is limited due to data silos and lack of automation, and stringent regulatory certification hinders quality assurance. However, three key vulnerabilities have increasingly attracted attention: (a) dependence on single-source suppliers for critical products, (b) just-in-time inventory management without buffer stock, and (c) fragmented global logistics susceptible to border disruptions during crises. These vulnerabilities do not merely raise costs or reduce service levels; they directly affect patient safety and compromise health systems' resilience.
All supply chains are vulnerable to disruption, whether through natural disasters, infrastructure failure, geopolitical tension or, as demonstrated in the COVID-19 pandemic, global health crises. The pharmaceutical and medical device supply chains are no exceptions. These sectors, hitherto operating under a veneer of relative stability, are now reassessing strategies in order to mitigate catastrophe — and attention is shifting to solutions that go beyond individual enterprise-level adaptations.
References
[1] Bown, C. P. (2022). Vaccine supply chain resilience and international cooperation. Peterson Institute for International Economics Working Paper, 22-15.
[2] Dogbe, C. S. K., Osei-Wusu, A., & Opoku, E.. Analyzing the health supply chain risks during COVID-19: The moderating role of risk management practices. Cogent Business & Management, 10(1), 2281716.
[3] Fahrni, M. L., Ismail, I. A.-N., Refi, D. M., Almeman, A., Yaakob, N. C., Saman, K. M., & Mansor, N. F. (2022). Management of COVID-19 vaccines cold chain logistics: A scoping review. Journal of Pharmaceutical Policy and Practice, 15(1), 16.
[4] Falagara Sigala, I., Sirenko, M., Comes, T., & Kovács, G. (2022). Mitigating personal protective equipment (PPE) supply chain disruptions in pandemics: A system dynamics approach. International Journal of Operations & Production Management, 42(13), 128–154.
[5] Gebhardt, M., Spieske, A., Kopyto, M., & Birkel, H. (2022). Increasing global supply chains’ resilience after the COVID-19 pandemic: A learning perspective. International Journal of Logistics Management, 33(2), 657–679.
[6] Golan, M. S., Jernegan, L. H., & Linkov, I. (2020). Trends and applications of resilience analytics in supply chain modeling: Systematic literature review in the context of the COVID-19 pandemic. Environment Systems and Decisions, 40(2), 222–243.
[7] Haleem, A., Javaid, M., Vaishya, R., & Deshmukh, S. G. (2022). Effects of COVID-19 pandemic on medical equipment’s supply chain: A brief review. Current Medicine Research and Practice, 12(6), 337–343.
[8] Handfield, R., Apte, A., & Finkenstadt, D. J. (2022). Developing supply chain immunity for future pandemic disruptions. Journal of Humanitarian Logistics and Supply Chain Management, 12(4), 482–501.
[9] Ivanov, D., & Dolgui, A. (2021). A digital supply chain twin for managing the disruption risks and resilience in the era of Industry 4.0. Production Planning & Control, 32(9), 775–788.
[10] Jifar, W. W., Gebremedhin, G. B., Alaklabi, A. M., & Abdulrahman, S. A. (2022). The impact of COVID-19 on pharmaceutical shortages and supply disruptions for non-communicable diseases among public hospitals of South West Oromia, Ethiopia. Journal of Multidisciplinary Healthcare, 15, 2143–2154.
[11] Khan, S., Haleem, A., & Deshmukh, S. G. (2021). Exploring the impact of COVID-19 pandemic on medical supply chain disruption. International Journal of Manufacturing Research, 16(3), 260–280.
[12] Kumar, P., Singh, R. K., & Dey, P. K. (2022). Learnings from COVID-19 for managing humanitarian supply chain disruptions. Journal of Humanitarian Logistics and Supply Chain Management, 12(2), 282–305.
[13] Lau, Y.-Y., Dulebenets, M. A., Yip, H.-T., & Tang, Y.-M. (2022). Healthcare supply chain management under COVID-19 settings: The existing practices in Hong Kong and the United States. Healthcare, 10(8), 1549.
[14] Linkov, I., & Trump, B. D. (2022). The science and practice of resilience. Springer.
[15] Mattingly, T. J., 2nd, & Mullins, C. D. (2022). Ensuring a high-quality and resilient supply chain: An imperative for essential medicines. Journal of Managed Care & Specialty Pharmacy, 28(5), 573–576.
[16] Moosavi, J., & Fathollahi-Fard, A. M. (2022). Supply chain disruption during the COVID-19 pandemic: Recognizing potential disruption management strategies. International Journal of Logistics Research and Applications, 25(2), 174–196.
[17] Nabipour, M., Ülkü, M. A., & Sedighi, M. (2021). On deploying blockchain technologies in supply chain strategies and the COVID-19 pandemic: A systematic literature review and research outlook. Sustainability, 13(19), 11083.
[18] Ocicka, B., & Raźniewski, P. (2022). Creating supply chain resilience during and post-COVID-19: The role of ambidexterity and digitalization. Operations Management Research, 15(1–2), 149–161.
[19] Pambudi, N. A., Sarifudin, A., Septiadi, W. N., Romadhoni, R., Ristianingsih, Y., Syaiful, H., Nissa, I. A., & Jufri, A. P. (2021). Vaccine cold chain management and cold storage technology to address the challenges of vaccination programs. Energy Reports, 7, 955–972.
[20] Patel, V., Cieslak, K., & Hertig, J. B.. Improving safety by evaluating the impact of the supply chain and drug shortages on health-systems. Hospital Pharmacy, 58(2), 120–124.
[21] Paul, S. K., Moktadir, M. A., Paul, A., & Hossain, M. (2021). Supply chain recovery challenges in the wake of COVID-19 pandemic. Journal of Business Research, 136, 316–329.
[22] Queiroz, M. M., Ivanov, D., Dolgui, A., & Fosso Wamba, S. (2020). Impacts of epidemic outbreaks on supply chains: Mapping a research agenda amid the COVID-19 pandemic through a structured literature review. Annals of Operations Research, 319(1), 1159–1196.
[23] Rab, S., Afzaal, M., & Bashir, S. (2022). Supply chain and logistics for COVID-19 vaccines: A review of challenges and opportunities. Anaesthesia, Pain & Intensive Care, 26(1), 45–52.
[24] Saha, E., Rathore, P., Parida, R., & Rana, N. P. (2022). The interplay of emerging technologies in pharmaceutical supply chain performance: An empirical investigation for the rise of Pharma 4.0. Technological Forecasting and Social Change, 181, 121770.
[25] Salahuddin, M., Manzar, M. D., & Alam, M. M. (2022). The global shortage of essential drugs during the COVID-19 pandemic: Evidence based on aggregated media and social media reports. Journal of Neuroscience Nursing, 54(3), 111–116.
[26] Saravanan, N., Jeyaraj, A., Kumar, S., & Vimal, K. E. K. (2022). Bibliometric and text analytics approaches to review COVID-19-related supply chain literature. Sustainability, 14(23), 15943.
[27] Spieske, A., Gebhardt, M., Kopyto, M., & Birkel, H. (2022). Improving resilience of the healthcare supply chain in a pandemic: Evidence from Europe during the COVID-19 crisis. Journal of Purchasing and Supply Management, 28(5), 100748.
[28] Tortorella, G. L., Fogliatto, F. S., Saurin, T. A., Tonetto, L. M., & McFarlane, D. (2022). Contributions of Healthcare 4.0 digital applications to the resilience of healthcare organizations during the COVID-19 outbreak. Technovation, 111, 102381.
[29] Tortorella, G. L., Saurin, T. A., Fogliatto, F. S., Rosa, V. M., Tonetto, L. M., & Magrabi, F. (2021). Impacts of Healthcare 4.0 digital technologies on the resilience of hospitals. Technological Forecasting and Social Change, 166, 120666.
[30] Yousefi, N., & Saen, R. F. (2022). A resilient supplier selection model for healthcare supply chains during epidemic outbreaks. Computers & Industrial Engineering, 170, 108235.
[31] Zhang, Y., & Dulebenets, M. A. (2022). Sustainable and resilient medical supply chains under COVID-19: Review and future research directions. Transportation Research Part E: Logistics and Transportation Review, 164, 102794.
[32] Furstenau, L. B., Zani, C., Terra, S. X., Sott, M. K., Choo, K.-K. R., & Saurin, T. A. (2022). Resilience capabilities of healthcare supply chain and supportive digital technologies. Technology in Society, 71, 102095.
[33] AlRuthia, Y., Alwhaibi, M., Alotaibi, M. F., Asiri, Y., Alshammari, M., & Almutairi, A.. Local causes of essential medicines shortages from the perspectives of pharmaceutical supply chain stakeholders. Saudi Pharmaceutical Journal, 31(6), 101184.
Additional Files
Published
Data Availability Statement
None
